Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Bob Coughlin, CEO of MassBio explains the amazing 51% growth in the biotech work force in Massachusetts in the last nine years.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Bob Coughlin, CEO of MassBio explains the amazing 51% growth in the biotech work force in Massachusetts in the last nine years.
Released on: October 14, 2011. © PharmaTelevision Ltd
Visitors: You are watching a 5 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks to Bob Coughlin, CEO of MassBio
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Key changes Biotech industry in Boston over the last year
Fintan Walton:
Hello and welcome to PharmaTelevision News Review here in Boston at BioPharm America. On this show I have Bob Coughlin, who is the CEO of MassBio based across here in Boston, welcome to the show.
Robert K. Coughlin:
Hello Fintan, thanks for having me.
Fintan Walton:
Well it was a year ago when we did have a previous interview Bob so as I said you are the CEO of MassBio you must have your finger on the pulse of what's going on here locally in the Boston area?
Robert K. Coughlin:
Yes we certainly do, I am having a hard time believing that that was a year ago already.
Fintan Walton:
Yes exactly.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Fintan Walton
Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).
Robert K Coughlin
President
Robert K. Coughlin currently serves as President & CEO of Massachusetts Biotechnology Council (MassBio). As President and CEO of the Massachusetts Biotechnology Council , Bob's mission is to foster a positive environment that enables each biotechnology company to achieve its full potential in Massachusetts, making the state a world center for biotechnology. He is very familiar with all areas of the Massachusetts life sciences super cluster and is a passionate advocate for research and the biotechnology community. Bob has spent his career in both the public and private sectors, most recently serving as Undersecretary of Economic Development within Governor Deval Patrick's administration in 2007. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. In the legislature both healthcare and economic development were his priorities. In the world of business he specialized in the environmental services industry and moved on to capital management and venture capital. He has held senior executive positions in both fields. He is a graduate of the Massachusetts Maritime Academy where he majored in Marine Engineering, and is a Lieutenant in the United States Naval Reserve. Coughlin has also been active in the community, having served on the boards of the Massachusetts Maritime Academy and Beth Israel Deaconess Hospital. He has served as the honorary chairman of the Great Strides Cystic Fibrosis Walk since 1996. In 2009, he co-chaired the Children's Hospital Boston signature event, Champions for Children's.
PharmaVentures
PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.
Massachusetts Biotechnology Council (MassBio)
The Massachusetts Biotechnology Council a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.